» Articles » PMID: 32946822

Diabetes in Ageing: Pathways for Developing the Evidence Base for Clinical Guidance

Abstract

Older adults with diabetes are heterogeneous in their medical, functional, and cognitive status, and require careful individualisation of their treatment regimens. However, in the absence of detailed information from clinical trials involving older people with varying characteristics, there is little evidence-based guidance, which is a notable limitation of current approaches to care. It is important to recognise that older people with diabetes might vary in their profiles according to age category, functional health, presence of frailty, and comorbidity profiles. In addition, all older adults with diabetes require an individualised approach to care, ranging from robust individuals to those residing in care homes with a short life expectancy, those requiring palliative care, or those requiring end-of-life management. In this Review, our multidisciplinary team of experts describes the current evidence in several important areas in geriatric diabetes, and outlines key research gaps and research questions in each of these areas with the aim to develop evidence-based recommendations to improve the outcomes of interest in older adults.

Citing Articles

How do sex-specific BMI trajectories shape diabetes risk? A longitudinal analysis of Indonesian adults.

Liwin L, Payne C BMJ Public Health. 2025; 1(1):e000020.

PMID: 40017894 PMC: 11812683. DOI: 10.1136/bmjph-2023-000020.


Prescribing Trends of Glucose-Lowering Medications Near End of Life Among Adults With Type 2 Diabetes: A Cohort Study.

Kutz A, Kim D, Liu J, Munshi M, Patorno E Diabetes Care. 2025; 48(3):455-463.

PMID: 39746144 PMC: 11870286. DOI: 10.2337/dc24-1795.


Nutritional Interventions in Older Persons with Type 2 Diabetes and Frailty: A Scoping Systematic Review.

Giraldo Gonzalez G, Gonzalez Robledo L, Jaimes Montana I, Benjumea Salgado A, Pico Fonseca S, Arismendi Solano M J Cardiovasc Dev Dis. 2024; 11(9).

PMID: 39330347 PMC: 11605221. DOI: 10.3390/jcdd11090289.


Frailty Detection in Older Adults with Diabetes: A Scoping Review of Assessment Tools and Their Link to Key Clinical Outcomes.

Guevara E, Simo-Servat A, Perea V, Quiros C, Puig-Jove C, Formiga F J Clin Med. 2024; 13(17).

PMID: 39274537 PMC: 11396781. DOI: 10.3390/jcm13175325.


Should dietary restrictions be imposed on Alzheimer's Disease patients affected by type 2 diabetes?.

Stefanescu C, Davidson M Dialogues Clin Neurosci. 2024; 26(1):53-55.

PMID: 39150448 PMC: 11332299. DOI: 10.1080/19585969.2024.2392491.


References
1.
Sinclair A, Morley J, Rodriguez-Manas L, Paolisso G, Bayer T, Zeyfang A . Diabetes mellitus in older people: position statement on behalf of the International Association of Gerontology and Geriatrics (IAGG), the European Diabetes Working Party for Older People (EDWPOP), and the International Task Force of Experts in.... J Am Med Dir Assoc. 2012; 13(6):497-502. DOI: 10.1016/j.jamda.2012.04.012. View

2.
Misso M, Egberts K, Page M, OConnor D, Shaw J . Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus. Cochrane Database Syst Rev. 2010; (1):CD005103. DOI: 10.1002/14651858.CD005103.pub2. View

3.
Lipska K, Wang Y, Kosiborod M, Masoudi F, Havranek E, Krumholz H . Discontinuation of antihyperglycemic therapy and clinical outcomes after acute myocardial infarction in older patients with diabetes. Circ Cardiovasc Qual Outcomes. 2010; 3(3):236-42. DOI: 10.1161/CIRCOUTCOMES.109.887620. View

4.
Lipska K, de Rekeneire N, Van Ness P, Johnson K, Kanaya A, Koster A . Identifying dysglycemic states in older adults: implications of the emerging use of hemoglobin A1c. J Clin Endocrinol Metab. 2010; 95(12):5289-95. PMC: 2999974. DOI: 10.1210/jc.2010-1171. View

5.
Lee S, Leipzig R, Walter L . Incorporating lag time to benefit into prevention decisions for older adults. JAMA. 2013; 310(24):2609-10. PMC: 4049260. DOI: 10.1001/jama.2013.282612. View